Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
The small RNA mascRNA differentially regulates TLR-induced proinflammatory and antiviral responses
Tao Sun, … , Yuqing Hu, Xiaohua Mao
Tao Sun, … , Yuqing Hu, Xiaohua Mao
Published September 28, 2021
Citation Information: JCI Insight. 2021;6(21):e150833. https://doi.org/10.1172/jci.insight.150833.
View: Text | PDF
Research Article Immunology

The small RNA mascRNA differentially regulates TLR-induced proinflammatory and antiviral responses

  • Text
  • PDF
Abstract

MALAT1-associated small cytoplasmic RNA (mascRNA) is a highly conserved transfer RNA–like (tRNA-like) noncoding RNA whose function remains largely unknown. We show here that this small RNA molecule played a role in the stringent control of TLR-mediated innate immune responses. mascRNA inhibited activation of NF-κB and mitogen-activated protein kinase (MAPK) signaling and the production of inflammatory cytokines in macrophages stimulated with LPS, a TLR4 ligand. Furthermore, exogenous mascRNA alleviated LPS-induced lung inflammation. However, mascRNA potentiated the phosphorylation of IRF3 and STAT1 and the transcription of IFN-related genes in response to the TLR3 ligand poly(I:C) both in vitro and in vivo. Mechanistically, mascRNA was found to enhance K48-linked ubiquitination and proteasomal degradation of TRAF6, thereby negatively regulating TLR-mediated MyD88-dependent proinflammatory signaling while positively regulating TRIF-dependent IFN signaling. Additionally, heterogeneous nuclear ribonucleoprotein H (hnRNP H) and hnRNP F were found to interact with mascRNA, promote its degradation, and contribute to the fine-tuning of TLR-triggered immune responses. Taken together, our data identify a dual role of mascRNA in both negative and positive regulation of innate immune responses.

Authors

Tao Sun, Chunxue Wei, Daoyong Wang, Xuxu Wang, Jiao Wang, Yuqing Hu, Xiaohua Mao

×

Figure 5

mascRNA potentiates TLR3 signaling by promoting TRAF6 degradation.

Options: View larger image (or click on image) Download as PowerPoint
mascRNA potentiates TLR3 signaling by promoting TRAF6 degradation.
(A an...
(A and B) qPCR analysis of Ifnb and IFN-induced gene expression in mascRNA-knockdown (A) or mascRNA-overexpressing RAW264.7 macrophages (B). Cells were transfected with mascRNA ASO or mascRNA-expressing vector and then stimulated with poly(I:C) for the indicated times. (C) mascRNA promotes poly(I:C)-triggered TRIF/TRAF3 signaling. mascRNA-overexpressing RAW264.7 cells were stimulated with poly(I:C) for the indicated times, followed by immunoblot analysis. (D) Kinetics of mascRNA and Ifnb mRNA abundance in poly(I:C)-stimulated RAW264.7 cells. RNA was quantified by qPCR. (E) mascRNA decreases TRAF6 while increases TRAF3 protein abundance upon poly(I:C) stimulation. RAW264.7 cells transfected with pGV-mascRNA were stimulated with poly(I:C), followed by immunoblot analysis. (F) Quantitative comparison of protein expression between mascRNA-overexpressing and control cells by density scanning of the blots in E. (G) mascRNA increases poly(I:C)-induced K48-linked ubiquitination of TRAF6, while it decreases K48-linked ubiquitination of TRAF3. mascRNA-overexpressing or control cells were stimulated with poly(I:C) for 15 minutes and immunoprecipitated with an anti-TRAF6 or anti-TRAF3 antibody, followed by immunoblot analysis with anti-ubiquitin, anti–K48-linked ubiquitin, anti-TRAF6, or anti-TRAF3. Immunoblot analysis of TRAF3, TRAF6, and β-actin in lysates without immunoprecipitation. Ubiquitination levels were normalized to β-actin and quantified (n = 3 independent experiments, mean ± SEM). NC, negative control. Data shown in A, B, and D are mean ± SD of triplicate wells. *P < 0.05; **P < 0.01; ***P < 0.001 (2-tailed Student’s t test). Data shown in A–F are representatives of 2 independent experiments.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts